Dr. Rachel Miller, M.D.
Claim this profileUniversity of Kentucky
Studies Ovarian Cancer
Studies Cancer
6 reported clinical trials
14 drugs studied
Area of expertise
1Ovarian Cancer
AKT positive
BRCA1 positive
PI3K positive
2Cancer
Stage IV
BRCA1 negative
BRCA2 negative
Affiliated Hospitals
Clinical Trials Rachel Miller, M.D. is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
ZEN-3694 + Talazoparib
for Cancer
This trial tests if combining ZEN-3694 and talazoparib can shrink advanced tumors that don't respond to standard treatments. ZEN-3694 blocks proteins that help tumors grow, and talazoparib stops cancer cells from fixing their damaged DNA, causing them to die. The study also looks at how patients' genes affect their response to this treatment. Talazoparib is a potent PARP inhibitor that has shown significant efficacy in treating advanced BRCA1 and BRCA2 mutated breast cancer.
Recruiting1 award Phase 230 criteria
More about Rachel Miller, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Rachel Miller, M.D. has experience with
- Paclitaxel
- Afuresertib
- Mirvetuximab Soravtansine
- Bevacizumab
- Therapeutic Intervention
- ZEN-3694
Breakdown of trials Rachel Miller, M.D. has run
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Miller, M.D. specialize in?
Rachel Miller, M.D. focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved AKT positive patients, or patients who are BRCA1 positive.
Is Rachel Miller, M.D. currently recruiting for clinical trials?
Yes, Rachel Miller, M.D. is currently recruiting for 3 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Rachel Miller, M.D. has studied deeply?
Yes, Rachel Miller, M.D. has studied treatments such as Paclitaxel, Afuresertib, Mirvetuximab Soravtansine.
What is the best way to schedule an appointment with Rachel Miller, M.D.?
Apply for one of the trials that Rachel Miller, M.D. is conducting.
What is the office address of Rachel Miller, M.D.?
The office of Rachel Miller, M.D. is located at: University of Kentucky, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.